Mission
To revolutionize global health and well-being through the seamless integration of advanced bionanotechnology. Our mission is to empower individuals and communities worldwide to unlock their full potential, overcome the constraints of disease and aging, and usher in a new era of human flourishing.
Vision
Imagine a world where the human body is an orchestra of precision-engineered, nano-scale components, working in perfect harmony to optimize health, performance, and longevity. This is the world that the convergence of bio-nanotechnology is poised to create.
Revolutionary Bioenhancer
By harnessing the power of nanoparticles, nanomachines, and other cutting-edge nano-scale technologies, we will develop a new generation of bioenhancers that can precisely target, monitor, and manipulate the body’s cellular and molecular processes. These bioenhancers will not only enhance the efficacy of therapeutic interventions but also proactively maintain and rejuvenate the body’s systems, ushering in a new era of personalized, preventive, and restorative healthcare.
From the nano-scale repair of damaged tissues to the targeted delivery of tailored treatments, these bioenhancers will revolutionize the management of diseases, from cancer and neurodegenerative disorders to metabolic conditions and age-related decline. By seamlessly integrating with the body’s natural mechanisms, these nano-bioenhancers will empower individuals to take control of their health, unlock their physical and cognitive potential, and enjoy longer, healthier, and more fulfilling lives.
Bioenhancer Vs Nanoencapsulation
Targeted Delivery & Specificity
Improved Biocompatibility & Safety
Multifunctional Design
Multimodal Functionality
SynergisticEffects
Controlled Release &Pharmacokinetics
Key Features of BioenhanczTM
“BioenhanczTM is the nanoengineered natural that unlocks the full potential of therapeutic bioactives by dramatically boosting their bioavailability through a multifaceted arsenal of permeability enhancement, efflux pump inhibition, metabolic enzyme modulation, and solubility optimization – transforming even the most challenging drugs/bioactives into powerful, well-absorbed treatment, without compromising safety and stability
Patent & Awards
U.S. Provisional Patent Application No.: 63/517,659
Entitled: QUERCETIN COCRYSTALS AS A BIOENHANCER OF DRUGS AND NUTRIENTS, PROCESS OF ITS PREPARATION
Filing Date: 04-Aug-2023
Platinum medal
PRIX EIFFEL 2022
Applicable Industries
Medical & Pharma
(e.g. Reduced Toxicity Tylenol Drug)
Nutraceutical
(e.g. Fast-Acting Supplement, Nootropics)
Pet Food & Treat
(e.g. Improved Health & Function Supplement)
Sport Drink & Food
(e.g. Enhanced Performance & Physical Function Drink Supplement)
Functional Drink & Food
(e.g. Increased Accessibility of Nutrients)
Military & Defense
(e.g. Specialized Performance-Enhancing Supplement, Resilience)
Cosmeceutical
(e.g. Enhanced Skin’s Natural Processes (Permeability) with Less Side Effect)
Agricultural
(e.g. Enhanced Plant Growth Boosting Vaccine)
Synergy with Bioactives
| Vitamin | Vitamin B | Nicotinamide | Lycopene | Caffeine | Anthocyanin |
| Folic acid | Vitamin A | Collagen | Resveratrol | Lutein | Whey |
| Glutathione | Riboflavin | CoQ10 | Collagen Tripeptide | b Carotene | Cannabinoids |
BioenhanczTM Minimizes The Toxicity of APIs
BioEnhancz™ has been investigated for its potential to reduce the hepatotoxicity of cannabidiol (through the inhibition of elevation of hepatic enzymes) which could be extended to the application of other highly hepatotoxicity of APIs, e.g. Acetaminophen (Tylenol/Paracetamol). BioEnhancz™ affects the inactivation the conversion of acetaminophen to its toxic metabolite, N-acetyl-p-benzoquinoneimine (NAPQI).
This metabolite is primarily formed by the cytochrome P4502E1 (CYP2E1) metabolic pathway when acetaminophen is administered at therapeutic doses or overdose.
The research findings indicating that BioEnhancz™ inhibits cytochrome P4502E1 (CYP2E1) which inhibits the conversion of acetaminophen to NAPQI demonstrating the potential benefits of BioEnhancz™ in reducing hepatotoxicity related APIs.
Meet the Team
Phanthep Chatnarat
CEO
With over 25 years of extensive experience in the technology sector and management information systems across ASEAN countries, I have a distinguished track record of delivering transformative results. My strategic acumen in market expansion and channel management has consistently driven business growth and innovation. My expertise lies in identifying and capitalizing on market opportunities, optimizing operations, and implementing cutting-edge technologies that enhance efficiency and profitability.
Dr.Srung Smanmoo
CTO
Chief Technology Officer with over 20 years of experience in leading technology strategies within the chemistry, pharmaceuticals, and drug discovery sectors. Skilled in driving innovation, managing large-scale projects, and leading cross-functional teams. Expertise in chemical research, pharmaceutical development, and drug discovery processes. Known for strategic vision and translating complex scientific concepts into actionable business plans to drive growth. Committed to fostering a culture of continuous improvement and excellence.
